Lps Treatment Protocol
Lps Treatment Protocol - Related Videos
08:51
Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic
0 Views •
Cited by 14 •
2012
Described here is a technique in which lipopolysaccharide is injected into the lactating mouse mammary gland via the nipple to simulate mastitis, a condition commonly caused by bacterial infection. Lipopolysaccharide injection results in increased nuclear factor kappa B (NF-κB) signaling, visualized through bioluminescent imaging of an NF-κB luciferase reporter mouse.
10:29
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
0 Views •
Cited by 83 •
2010
In this article, we examine the methodology and considerations relevant to the FDA approved depression treatment protocol using the Neuronetics NeuroStar TMS device.
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
0 Views •
Cited by 4 •
2017
Antibiotic efficacy is most commonly determined by conducting killing kinetic studies and measuring colony forming units (CFUs). By integrating scanning electron microscopy (SEM) with these standard methods, we can distinguish the pharmacological effects of treatment between different antibiotics.
03:50
A Treatment Protocol for Achilles Tendinopathy with Extracorporeal Shockwave Therapy
0 Views •
Cited by 1 •
2024
Achilles tendinopathy is a common musculoskeletal condition for which loading programs are currently the standard of care. However, the treatment protocols vary. We therefore propose a protocol for Achilles tendinopathy treatment using extracorporeal shockwave therapy.
04:12
An In Vitro Technique to Study Antimicrobial Treatments on Bacterial Aggregates
0 Views •
2025
This video demonstrates an in vitro technique to study the impact of antimicrobial treatment on Pseudomonas aeruginosa (Pa) aggregates. Fluorescently-labeled Pa cells are grown as aggregates, mimicking the growth pattern during infection. Upon challenging the aggregates with a sublethal concentration of the antibiotic colistin, the real-time assessment of the bacteria-antibiotic interaction is performed via fluorescence microscopy.
FAQs
LPS engagement of CD14–MD-2–TLR4 initiates intracellular signaling that activates pathways including NF-κB. This signaling provides the mechanistic link between exposure and subsequent production of inflammatory mediators. Measuring those mediators allows researchers to connect receptor activation with measurable immune-cell or organism-level responses, helping characterize how innate immune activation develops under defined experimental conditions.
LPS concentration and exposure time are central variables because researchers adjust them to examine different cytokine responses, immune-cell activation states, and inflammatory outcomes. Experimental controls are also essential for interpreting whether a measured change reflects LPS exposure or another experimental factor. Keeping these conditions defined enables comparisons among inflammatory phenotypes and treatment groups.
Cytokine responses provide measurable evidence of the inflammatory signaling triggered after LPS exposure. When evaluated alongside immune-cell activation or broader inflammation, they help distinguish the response profile produced under particular treatment conditions. This information supports comparisons between experimental models and can reveal whether a candidate treatment changes the intensity or pattern of innate immune activation.
A protocol begins by selecting an immune-cell or experimental-organism model, then exposing it to defined LPS conditions. Researchers specify the concentration and exposure time, include appropriate experimental controls, and assess outcomes such as cytokine production, immune-cell activation, or inflammation. Comparing these measurements across conditions provides a structured way to evaluate inflammatory responses.
Controls establish the basis for deciding whether observed cytokine production, immune-cell activation, or inflammation is associated with LPS exposure. They also support comparisons when researchers vary concentration, exposure time, or an added treatment. Without clearly defined controls, differences among experimental groups are harder to attribute to the intended inflammatory stimulus or intervention.
In immunology and infection research, LPS treatment helps model aspects of innate immune activation relevant to host–pathogen interactions. Researchers can compare inflammatory phenotypes and evaluate candidate anti-inflammatory or immunomodulatory treatments by measuring changes in cytokine responses, immune-cell activation, or inflammation. The approach therefore connects controlled stimulation with questions about host responses and therapeutic effects.